Pharmacological Intervention to Modulate HDL: What Do We Target?

by Nicholas J. Woudberg, Sarah Pedretti, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard W. James, Miguel A. Frias, Miguel A. Frias
Published 2018-01-01

HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3.

by Sarah Pedretti, Marie-Claude Brulhart-Meynet, Fabrizio Montecucco, Sandrine Lecour, Richard W James, Miguel A Frias
Published 2019-01-01

Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation

by Sabrina Pagano, Alessandra Magenta, Marco D’Agostino, Francesco Martino, Francesco Barillà, Nathalie Satta, Miguel A. Frias, Annalisa Ronca, François Mach, Baris Gencer, Elda Favari, Nicolas Vuilleumier
Published 2019-11-01

Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment

by Marie‐Claude Brulhart‐Meynet, Aurélien Thomas, Jonathan Sidibé, Florian Visentin, Rodolphe Dusaulcy, Valérie Schwitzgebel, Zoltan Pataky, Jacques Philippe, Nicolas Vuilleumier, Richard W. James, Yvan Gosmain, Miguel A. Frias
Published 2021-03-01

Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.

by Marie-Claude Brulhart-Meynet, Vincent Braunersreuther, Jonas Brinck, Fabrizio Montecucco, Jean-Christophe Prost, Aurelien Thomas, Katia Galan, Graziano Pelli, Sarah Pedretti, Nicolas Vuilleumier, François Mach, Sandrine Lecour, Richard W James, Miguel A Frias
Published 2015-01-01